May 27, 2020
Leading Thrombosis Specialists Issue Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19
May 12, 2020
ASH to Develop Clinical Practice Guidelines on the Use of Anticoagulation in Patients with COVID-19
May 06, 2020
FDA Clears New Mechanical Thrombectomy Platform
Apr 22, 2020
Deep Vein Thrombosis (DVT) Pipeline Insights, H1 2020; Therapeutics, Drugs, Products, Key Players
Mar 28, 2020
Landmark Phase 3 VOYAGER PAD Study of XARELTO® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
Mar 02, 2020
$4.2 Billion Compression Therapy Industry (2019 to 2025) - Growth Potential Offered By Emerging Markets Presents Opportunities
Mar 02, 2020
$4.2 Billion Compression Therapy Industry (2019 to 2025) - Growth Potential Offered By Emerging Markets Presents Opportunities
Mar 02, 2020
$4.2 Billion Compression Therapy Industry (2019 to 2025) - Growth Potential Offered By Emerging Markets Presents Opportunities
Feb 21, 2020
Compression Therapy Market Worth $4.2 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Jan 03, 2020
UNC School of Medicine Expert Helps Treat Astronaut’s Blood Clot During NASA Mission
Dec 23, 2019
FDA approves first generics of Eliquis
Dec 23, 2019
Traveling for the Holidays? Start with a Healthy Approach
Dec 06, 2019
Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System - a Mechanical Device for Treatment of DVT
Nov 20, 2019
The global thrombectomy devices market is expected to reach US$ 2,101.29 Mn in 2027 from US$ 1,282.07 Mn in 2018
Oct 10, 2019
FDA Clears GEKO DEVICE for Use in Non-surgical Patients at Risk for Deep Vein Thrombosis Based on Study Demonstrating a Zero Percent DVT Rate in Patients After a Stroke
Oct 09, 2019
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots
Sep 20, 2019
XARELTO® (rivaroxaban) Reduces Recurrent Blood Clots and Total Medical Costs in Morbidly Obese Patients
Sep 03, 2019
New Study: Low-Intensity Warfarin Not as Effective as Conventional Warfarin to Prevent Clots after Joint Replacement
Aug 14, 2019
Heparin Market is Expected to Accumulate Revenues Worth US$16.3 Billion by 2025 - TMR
Jul 08, 2019
XARELTO® (rivaroxaban) Helps Protect Pediatric Patients from Blood Clots in Late-Breaking Phase 3 EINSTEIN-Jr Study